Olema Pharmaceuticals Inc [OLMA] stock prices are up 0.95% to $6.35 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OLMA shares have gain 10.63% over the last week, with a monthly amount glided 18.25%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on August 12, 2025, when Citigroup reiterated its Buy rating and also boosted its price target to $21 from $20. Previously, Goldman started tracking the stock with Buy rating on April 02, 2024, and set its price target to $24. On January 30, 2024, Citigroup initiated with a Buy rating and assigned a price target of $20 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $21 on July 21, 2023. CapitalOne initiated its recommendation with a Overweight and recommended $16 as its price target on May 05, 2023. Credit Suisse started tracking with a Outperform rating for this stock on February 22, 2023, and assigned it a price target of $12.
The stock price of Olema Pharmaceuticals Inc [OLMA] has been fluctuating between $2.86 and $13.93 over the past year. Currently, Wall Street analysts expect the stock to reach $28.5 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $6.35 at the most recent close of the market. An investor can expect a potential return of 348.82% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
Gross Profit Margin for this corporation currently stands at -0.11% with Operating Profit Margin at -431.66%, Pretax Profit Margin comes in at -390.92%, and Net Profit Margin reading is -390.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.43 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.09 points at the first support level, and at 5.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.51, and for the 2nd resistance point, it is at 6.66.
Ratios To Look Out For
It’s worth pointing out that Olema Pharmaceuticals Inc [NASDAQ:OLMA]’s Current Ratio is 15.22. As well, the Quick Ratio is 15.22, while the Cash Ratio is 1.58.
Transactions by insiders
Recent insider trading involved Bain Capital Life Sciences Inv, 10% Owner, that happened on Jan 08 ’25 when 0.3 million shares were purchased. Director, Graham G. Walmsley completed a deal on Dec 17 ’24 to sell 0.7 million shares. Meanwhile, Affiliate Logos Opportunities Fund I LP bought 0.7 million shares on Dec 13 ’24.
